Connect Biopharma Holdings Ltd (CNTB)
Data as of , from SEC Form 4 filings.
See up to 3 months of CNTB. The 7-day demo opens the 1M and 3M ranges and puts CNTB on your watchlist.
Start 7-day demoLatest CNTB insider trades
James HuangOpen-market purchase$372K- James HuangOpen-market purchase$4.00M
Kleanthis Gabriel Xanthopoulos
About Connect Biopharma Holdings Ltd (CNTB)
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
- SAN DIEGO, CA
- 64
- 2025
- XNAS
https://www.connectbiopharm.comSEC filings for CNTB on EDGAR
CNTB Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 13,984 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CNTB insider transactions (Form 4)
88 Form 4 filings on record, the earliest from Apr 1, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kleanthis Gabriel Xanthopoulos - Director | Grant or award | Ordinary Shares | 5,000 footnote F1 | $0.00 | - | |
| ||||||
| Jean I. Liu - Director | Grant or award | Ordinary Shares | 8,984 footnote F1 | $0.00 | - | |
| ||||||
| Kleanthis Gabriel Xanthopoulos - Director | Grant or award | Ordinary Shares | 3,738 footnote F1 | $0.00 | - | |
| ||||||
| Jean I. Liu - Director | Grant or award | Ordinary Shares | 6,718 footnote F1 | $0.00 | - | |
| ||||||
| James Huang | Open-market purchase | Ordinary Shares | 150,000 | $2.48 footnote F1 | $372K | |
| ||||||
| Kleanthis Gabriel Xanthopoulos - Director | Grant or award | Ordinary Shares | 2,816 footnote F1 | $0.00 | - | |
| ||||||
| Jean I. Liu - Director | Grant or award | Ordinary Shares | 5,061 footnote F1 | $0.00 | - | |
| ||||||
| James Huang | Open-market purchase | Ordinary Shares | 1,160,000 | $3.45 | $4.00M | |
CNTB insider trading FAQ
What is the latest insider trade for CNTB?
Connect Biopharma Holdings Ltd (CNTB) had 2 insider filings in the last 90 days, with the most recent on 2026-10-01. The full record for CNTB runs to 8 Form 4 filings, the earliest from 2026-04-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CNTB stock?
No insider purchases of CNTB were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling CNTB stock?
No insider sales of CNTB were filed in the last 90 days.
Where can I see CNTB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CNTB Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
8The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kleanthis Gabriel Xanthopoulos view on EDGAR
- - Jean I. Liu view on EDGAR
- - Kleanthis Gabriel Xanthopoulos view on EDGAR
- - Jean I. Liu view on EDGAR
- - James Huang view on EDGAR
- - Kleanthis Gabriel Xanthopoulos view on EDGAR
- - Jean I. Liu view on EDGAR
- - James Huang view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CNTB's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CNTB with a 7-day demo
- CNTB on your watchlist
- Every CNTB Form 4 filing on record
- Up to 3 months of CNTB price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
